-
-
-
-
-
-
-
Lexicon Pharmaceuticals Reports Second Quarter 2022 Financial Results and Provides Business Update
-
-
-
-
-
-
-
CHMP Recommends Zynquistaâ„¢ (Sotagliflozin) for the Treatment of Adults With Type 1 Diabetes
-
-
-
-
-
-
-
Lexicon Pharma (LXRX), Sanofi (SNY) Announce FDA to Review Zynquista as Potential Treatment for Type 1 Diabetes
-
-
-
-
-
-
-
Lexicon Announces Publication Of TELESTAR Study Results For Telotristat Ethyl In The Journal Of Clinical Oncology
-
-
-
-
-
-
-
Lexicon Pharmaceuticals Provides Clinical Pipeline Update And Reports 2016 Second Quarter Financial Results
-
-
-
-
-
-
12,339 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All